Sera Prognostics announces Class A common stock offering

Sera Prognostics (SERA) announced that it has commenced a proposed underwritten public offering of its Class A common stock and, in lieu of Class A common stock to certain investors, pre-funded warrants to purchase shares of its Class A common stock. All of the shares and pre-funded warrants to be sold in the offering will be offered by Sera. Sera intends to use the net proceeds from the proposed offering to expand its commercial infrastructure and capabilities in the United States, accelerate preparations for expansion in the European Union, fund additional studies designed to increase adoption of the PreTRM test, including a potential submission to the FDA seeking broad approval of the PreTRM test, and for general corporate purposes. Jefferies, TD Cowen and William Blair are acting as joint book-running managers and RBC Capital Markets is acting as a bookrunner for the proposed offering.